Informa helps businesses and professionals in hundreds of ways.

Our international portfolio of live events, world-leading research publications, and innovative digital services provide specialists with the knowledge and connections they need to thrive.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Yusuke Iriyama
Head of the Drug Discovery Business Unit at Nissan Chemical Corporation
Speaker

Profile

Yusuke Iriyama is Head of the Drug Discovery Business Unit, Nissan Chemical’s Healthcare Business Development Department., where he is responsible for advancing R&D strategy and building external partnerships. He joined Nissan Chemical Corporation in 2006. He has spent more than ten years as a chemist working on oligonucleotide therapeutics, including antisense and siRNA modalities.